Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Underperform on Moderna, Lowers Price Target to $85

SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and lowers the price target from $86 to $85.
byBenzinga Newsdesk
January 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and lowers the price target from $86 to $85.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0